MIF098 (CD74 antagonist) in dogs: the evidence

What the aging-research databases and the canine literature hold for MIF098 (CD74 antagonist) (names searched: MIF098 (CD74 antagonist), MIF098-(CD74-antagonist)). Compiled from DrugAge, the canine aging corpus and FDA CVM FOI summaries; nothing here is inferred.

Lifespan experiments in other species (DrugAge)

2 experiments recorded, by species: Mus musculus 2.

NIA Interventions Testing Program rows

SpeciesStrainDoseAge at startDurationSexMean lifespan Δ%Mean sig.Max lifespan Δ%Max sig.Source
Mus musculusUM-HET3240 ppm food8 monthsuntil deathFemale-1NS-2NSPMID 33788371
Mus musculusUM-HET3240 ppm food8 monthsuntil deathMale4NS1NSPMID 33788371

Lifespan experiments in dogs (DrugAge)

DrugAge records no dog lifespan experiment for this compound.

Dog-equivalent doses (allometric starting points, not recommendations)

Method: FDA 2005 Km body-surface-area conversion; starting-point heuristic only.

No mg/kg dose in DrugAge to translate (doses reported as ppm of diet or a concentration).

Canine aging literature (Europe PMC corpus)

0 corpus records mention this compound.

Trials and cohorts in the canine aging trial registry

No registered study of this compound in dogs.

FDA CVM FOI summaries for dog products

No FDA FOI summary for a dog product contains this ingredient (it is not a marketed veterinary product).

Evidence gaps reported by the dossier tool

Reproduce: intervention_dossier(compound="MIF098 (CD74 antagonist)") in dog-geroscience-mcp.